OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
28
Results
Show all
Save search
Copy query
Show results for
Unknown
(28)
Publication Date
Release Date
2020
(16)
2023
(5)
2024
(3)
2022
(3)
2007
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Haplotype structure and selection of the MDM2 oncogene in humans.
Not available
S-EPMC1838634
|
biostudies-literature
Cite
Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice.
Not available
S-EPMC10581384
|
biostudies-literature
Cite
A cellular and molecular spatial atlas of dystrophic muscle.
Not available
S-EPMC10629561
|
biostudies-literature
Cite
A single-cell map of dynamic chromatin landscapes of immune cells in renal cell carcinoma.
Not available
S-EPMC9325682
|
biostudies-literature
Cite
Digital wearable insole-based identification of knee arthropathies and gait signatures using machine learning.
Not available
S-EPMC11152572
|
biostudies-literature
Cite
Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia : A Target Trial Emulation Using MINT Trial Data.
Not available
S-EPMC12701713
|
biostudies-literature
Cite
Anemia Acuity Effect on Transfusion Strategies in Acute Myocardial Infarction: A Secondary Analysis of the MINT Trial.
Not available
S-EPMC11530937
|
biostudies-literature
Cite
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.
Not available
S-EPMC10837004
|
biostudies-literature
Cite
Common and rare variant associations with clonal haematopoiesis phenotypes.
Not available
S-EPMC9713173
|
biostudies-literature
Cite
Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes.
Not available
S-EPMC9399235
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets